(Q44145165)

English

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia

scientific article published in August 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia (English)

1 reference

Europe PubMed Central

30 November 2017

1 reference

based on heuristic

inferred from title

6

object named as

Dudley J Pennell

1 reference

Europe PubMed Central

30 November 2017

author name string

Lisa J Anderson

1

1 reference

Europe PubMed Central

30 November 2017

Beatrix Wonke

2

1 reference

Europe PubMed Central

30 November 2017

Emma Prescott

3

1 reference

Europe PubMed Central

30 November 2017

Sally Holden

4

1 reference

Europe PubMed Central

30 November 2017

J Malcolm Walker

5

1 reference

Europe PubMed Central

30 November 2017

language of work or name

0 references

publication date

1 August 2002

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

360

1 reference

Europe PubMed Central

30 November 2017

9332

1 reference

Europe PubMed Central

30 November 2017

516-520

1 reference

Europe PubMed Central

30 November 2017

Survival and causes of death in thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Editorial retrospective. Iron loading in thalassemia--five years with the pump

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Iron-chelation therapy with oral deferiprone in patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term trial with the oral iron chelator 1, 2-dimethyl-3-hydroxypyrid-4-one (L1). I. Iron chelation and metabolic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Establishment and performance of a magnetic resonance cardiac function clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Iron excretion in thalassaemia major after administration of chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and desferrioxamine in thalassaemia major.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lifetime treatment costs of beta-thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ocular changes in patients undergoing long-term desferrioxamine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Deferoxamine-induced bone dysplasia in patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Deferoxamine-induced growth retardation in patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A risk-benefit assessment of iron-chelation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival in medically treated patients with homozygous beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

L1 (1,2-dimethyl-3-hydroxypyrid-4-one) for oral iron chelation in patients with beta-thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Deferiprone therapy in homozygous human beta-thalassemia removes erythrocyte membrane free iron and reduces KCl cotransport activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909740-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(02)09740-4

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44145165&oldid=2107106597"